ARTICLE | Company News
Management tracks: Alkermes, Helsinn
March 1, 2018 11:57 PM UTC
Neurology company Alkermes plc (NASDAQ:ALKS) hired James Robinson as president and COO. He was president of Americas operations at the Astellas US LLC unit of Astellas Pharma Inc. (Tokyo:4503).
Helsinn Therapeutics Inc., a U.S. subsidiary of cancer company Helsinn Healthcare S.A. (Lugano, Switzerland), said CEO William Mann will step down. He is succeeded by Paul Rittman, who was SVP and general manager of U.S. Oncology at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA)...